LONG-TERM SURVIVAL OUTCOMES WITH INTRAVESICAL NANOPARTICLE ALBUMIN-BOUND PACLITAXEL FOR RECURRENT NON-MUSCLE INVASIVE BLADDER CANCER AFTER PREVIOUS BACILLUS CALMETTE-GUERIN THERAPY

被引：0
|
作者：
Robins, Dennis J.
Sui, Wilson
Matulay, Justin T.
DeCastro, G. Joel
Anderson, Christopher B.
McKiernan, James M.
机构：
来源：
JOURNAL OF UROLOGY | 2017年 / 197卷 / 04期
关键词：
D O I：
10.1016/j.juro.2017.02.3263
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP21-01
引用
收藏
页码：E247 / E248
页数：2
相关论文
共 50 条
  • [41] Renal Granulomatosis Post Intravesical Bacillus Calmette-Guerin Therapy for Non-muscle-invasive Bladder Cancer
    Tran-Harding, Karen
    Nair, Rashmi T.
    Ganesh, Halemane
    [J]. JOURNAL OF CLINICAL IMAGING SCIENCE, 2018, 8
  • [42] A PROSPECTIVE COMPARATIVE STUDY OF INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) THERAPY WITH THE TOKYO OR CONNAUGHT STRAINS FOR NON-MUSCLE INVASIVE BLADDER CANCER
    Sengiku, Atsushi
    Ito, Masaaki
    Miyazaki, Yu
    Sawazaki, Harutake
    Takahashi, Takeshi
    Ogura, Keiji
    [J]. JOURNAL OF UROLOGY, 2013, 189 (04): : E734 - E734
  • [43] Phase I trial of intravesical Bacillus Calmette-Guerin combined with intravenous pembrolizumab in recurrent or persistent high-grade non-muscle-invasive bladder cancer after previous Bacillus Calmette-Guerin treatment
    Alanee, Shaheen
    Sana, Sherjeel
    El-Zawahry, Ahmed
    Peabody, James
    Pearce, Tiffany
    Adams, Nicole
    Deebajah, Mustafa
    Crabtree, Jane
    Delfino, Kristin
    McVary, Kevin
    Robinson, Kathy
    Rao, Krishna
    [J]. WORLD JOURNAL OF UROLOGY, 2021, 39 (10) : 3807 - 3813
  • [44] Phase II Trial of Intravesical Nanoparticle Albumin Bound Paclitaxel for the Treatment of Nonmuscle Invasive Urothelial Carcinoma of the Bladder after bacillus Calmette-Guerin Treatment Failure
    McKiernan, James M.
    Holder, Dara D.
    Ghandour, Rashed A.
    Barlow, LaMont J.
    Ahn, Jennifer J.
    Kates, Max
    Badalato, Gina M.
    Roychoudhury, Arindam
    Decastro, G. Joel
    Benson, Mitchell C.
    [J]. JOURNAL OF UROLOGY, 2014, 192 (06): : 1633 - 1638
  • [45] Effect of HLA genotype on intravesical recurrence after bacillus Calmette-Guerin therapy for non-muscle-invasive bladder cancer
    Kobayashi, Mizuki
    Fujiyama, Nobuhiro
    Tanegashima, Tokiyoshi
    Narita, Shintaro
    Yamamoto, Yoshiaki
    Fujimoto, Naohiro
    Ueda, Shohei
    Takeuchi, Ario
    Numakura, Kazuyuki
    Habuchi, Tomonori
    Matsuyama, Hideyasu
    Eto, Masatoshi
    Shiota, Masaki
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (03) : 727 - 736
  • [46] INTRAVESICAL BACILLUS CALMETTE - GUERIN: PATTERNS OF USE AND OUTCOMES FOR NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
    Huang, Dora
    Khan, Munad
    Azer, Sarah
    Sengupta, Shomik
    Lawrentschuk, Nathan
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 48 - 48
  • [47] INTRAVESICAL BACILLUS CALMETTE-GUERIN GLOBAL SHORTAGE: IMPACT ON THE MANAGEMENT OF NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
    Huang, Dora
    Khan, Munad
    Sengupta, Shomik
    Lawrentschuk, Nathan
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 47 - 47
  • [48] Bacillus Calmette-Guerin for the Treatment of Non-muscle Invasive Bladder Cancer: History and Current Status
    Liu, Gang
    Li, Bingheng
    Xu, Ziyang
    Wang, Jie
    Ma, Sai
    Kan, Yi
    Mao, Lijun
    [J]. DISCOVERY MEDICINE, 2022, 33 (169) : 85 - 92
  • [49] Pyuria as a Predictive Marker of Bacillus Calmette-Guerin Unresponsiveness in Non-Muscle Invasive Bladder Cancer
    Suh, Jungyo
    Yuk, Hyeong Dong
    Jeong, Chang Wook
    Kwak, Cheol
    Kim, Hyeon Hoe
    Ku, Ja Hyeon
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (17)
  • [50] Intravesical bacillus Calmette-Guerin immunotherapy after previous prostate radiotherapy for high-grade non-muscle-invasive bladder cancer
    Rao, Manoj V.
    Ellimoottil, Chandy
    Sondej, Timothy
    Flanigan, Robert C.
    Quek, Marcus L.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (06) : 857 - 861
12345